Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs

Abstract

In the article shows the questions of prevalence, diagnosis and prognostic significance of renal damage in metabolic syndrome. Discusses the pathogenetic mechanisms of development and progression of chronic kidney disease in individuals with obesity. Approaches to selection of antihypertensive drugs, advantages and limitations of the major classes of antihypertensive drugs in the treatment of metabolic syndrome, arterial hypertension combined with renal disease.

Keywords

• metabolic syndrome
• obesity
• hypertension
• microalbuminuria
• verapamil